Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-510.35%EBITDA Margin
VS
Market
Sector
Industry
History
$ 6.25Close
$ 5.94 - $ 21.99 52-Week Range
Ticker Information
Ticker
CAPRCompany Name
CAPRICOR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCAPRICOR THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CAPR - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -68.35M | -510.35% | $ 13.39M |
| 3/31/2025 | $ -53.57M | -308.49% | $ 17.36M |
| 12/31/2024 | $ -39.04M | -175.31% | $ 22.27M |
| 9/30/2024 | $ -32.76M | -141.02% | $ 23.23M |
| 6/30/2024 | $ -26.67M | -98.24% | $ 27.15M |
| 3/31/2024 | $ -23.14M | -85.4% | $ 27.1M |
| 12/31/2023 | $ -21.22M | -84.27% | $ 25.18M |
| 9/30/2023 | $ -28.29M | -201.38% | $ 14.05M |
| 6/30/2023 | $ -28.41M | -300.49% | $ 9.46M |
| 3/31/2023 | $ -28.46M | -513.84% | $ 5.54M |
Key Performance Insights, Last 5 Years
- CAPRICOR THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -2276.82%.
- Over the past 5 years, CAPRICOR THERAPEUTICS INC's average EBITDA % has been -2746.62%.
- The median EBITDA % for CAPRICOR THERAPEUTICS INC during this period was -513.84%
- CAPRICOR THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -84.27%.
- The lowest EBITDA % recorded by CAPRICOR THERAPEUTICS INC in the same timeframe -10835.27%
CAPRICOR THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for CAPRICOR THERAPEUTICS INC is calculated as follows: EBITDA [ $ -10.8M ] / Revenues [ $ 474.52K ]
(=) EBITDA % [ -2276.82% ] CAPR - EBITDA Margin, Last 5 years
-10835.27%
Minimum
Mar 31, 2022
-84.27%
Maximum
Dec 31, 2023
-2746.62%
Average
-513.84%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |